CheckMarte-026

Bristol-Myers Squibb Co (NYSE: BMY) saw its shares crater from near $75 last week to nearly $60 per share after the company reported a major setback for its cancer-treating drug, Opdivo. Bristol-Myers said Opdivo failed to meet a primary endpoint in the treatment of lung cancer during the...